Eng

Chinese university develops rapid test kit for novel coronavirus

XINHUA
發布於 2020年02月17日06:10

A staff member of Disease Control and Prevention Center of Saihan District takes sample from a resident for test in Hohhot, capital of north China's Inner Mongolia Autonomous Region, Feb.11, 2020. (Xinhua/Peng Yuan)

The new test kit can detect the virus in just 15 minutes.

廣告(請繼續閱讀本文)

TIANJIN, Feb. 17 (Xinhua) -- China's Nankai University has announced a breakthrough in developing a novel coronavirus rapid test kit that can identify infection among suspected patients within 15 minutes.

The new virus detection product, called Novel Coronavirus (2019-nCoV) IgM/IgG antibody detection kit, was developed by the century-old university based in northern China's Tianjin, together with a group of experts from other Chinese universities and biopharmaceutical companies.

The fast test card, part of the kit, can detect the virus in just 15 minutes.   

廣告(請繼續閱讀本文)

The test kit can shorten the testing time, provide easier and faster operation and make rapid diagnosis of suspected patients and on-site screening of people in close contact, the university said in a statement.

Nankai University in north China's Tianjin Municipality, Sept. 28, 2016. (Xinhua/Xing Guangli)

廣告(請繼續閱讀本文)

Last week, China's Ministry of Science and Technology solicited research projects on rapid test kits for the novel coronavirus, saying that current nucleic acid detection reagents take a long time and have intricate operations. They are unable to meet the fast-growing needs of the quick testing on suspected patients and asymptomatic infections.

A number of research teams across China are developing or have developed rapid testing products for the novel coronavirus.

The Nankai test kit is expected to be used in epidemic prevention and control soon, the university said.  ■

更多 Eng 相關文章

Israeli war cabinet directs negotiating team to resume talks on hostages deal
XINHUA
Tencent Announces Winners of Flagship CarbonX Program to Combat Climate Change
PR Newswire (美通社)
Antengene To Present One Oral and Four Abstracts at ASCO 2024
PR Newswire (美通社)
FOOMA JAPAN 2024: The Premier Exhibition for Food Manufacturing Technologies
PR Newswire (美通社)
Students Actively Implementing the Vision of Sustainable Development through Competition
PR Newswire (美通社)
Busting fear barrier about hormone replacement therapy in new era of menopause management
PR Newswire (美通社)
Chinese tea's fragrance drifts into hometown of Ceylon black tea
XINHUA
Scholars share China's economic outlook in Tokyo
XINHUA
Hyundai Motor and Plus Announce Collaboration to Demonstrate First Level 4 Autonomous Fuel Cell Electric Truck in the U.S.
PR Newswire (美通社)
China's BRI-backed workshop helps develop vocational skills for Cambodian talent
XINHUA
Xinhua Photo Daily | May 23, 2024
XINHUA
China's installed power generation capacity up 14.1 pct
XINHUA
South African parliament supports ICC warrants for Netanyahu, Hamas leaders
XINHUA
World Insights: U.S.-Europe divisions deepen as Norway, Ireland, Spain recognize Palestinian statehood
XINHUA
Young Chinese couples redefine weddings with simplicity and joy
XINHUA
Newly-appointed Milicic to bring modern style of play to China women's football team
XINHUA
Transcenta Debuts Encouraging Phase II Data from First-line Triple Combo Trial of Osemitamab (TST001) for G/GEJ Cancer at ASCO 2024
PR Newswire (美通社)